GapA+ Mycoplasma gallisepticum ts-11 has improved vaccine characteristics

References

1. Devlin J. M., Viejo-Borbolla A., Browning G. F., Noormohammadi A. H., Gilkerson J. R., Alcami A., Hartley C. A. ( 2010). Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine 28:1325–1332 [View Article][PubMed]
   [Google Scholar]
2. García M., Ikuta N., Levisohn S., Kleven S. H. ( 2005). Evaluation and comparison of various PCR methods for detection of Mycoplasma gallisepticum infection in chickens. Avian Dis 49:125–132 [View Article][PubMed]
   [Google Scholar]
3. Gaunson J. E., Philip C. J., Whithear K. G., Browning G. F. ( 2000). Lymphocytic infiltration in the chicken trachea in response to Mycoplasma gallisepticum infection. Microbiology 146:1223–1229[PubMed]
   [Google Scholar]
4. Gaunson J. E., Philip C. J., Whithear K. G., Browning G. F. ( 2006a). The cellular immune response in the tracheal mucosa to Mycoplasma gallisepticum in vaccinated and unvaccinated chickens in the acute and chronic stages of disease. Vaccine 24:2627–2633 [View Article][PubMed]
   [Google Scholar]
5. Gaunson J. E., Philip C. J., Whithear K. G., Browning G. F. ( 2006b). Age related differences in the immune response to vaccination and infection with Mycoplasma gallisepticum . Vaccine 24:1687–1692 [View Article][PubMed]
   [Google Scholar]
6. Geary S. J., Gabridge M. G. ( 1987). Characterization of a human lung fibroblast receptor site for Mycoplasma pneumoniae . Isr J Med Sci 23:462–468[PubMed]
   [Google Scholar]
7. Geary S. J., Gabridge M. G., Intres R., Draper D. L., Gladd M. F. ( 1989). Identification of Mycoplasma binding proteins utilizing a 100 kilodalton lung fibroblast receptor. J Recept Res 9:465–478[PubMed]
   [Google Scholar]
8. Goh M. S., Gorton T. S., Forsyth M. H., Troy K. E., Geary S. J. ( 1998). Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology 144:2971–2978 [View Article][PubMed]
   [Google Scholar]
9. Kanci A., Browning G. F., Geary S. J., Papazisi L., Gorton T. S., Markham P. F. ( 2004) Is an unstable repeat sequence responsible for the attenuation of the Mycoplasma gallisepticum vaccine strain ts-11?. 15th Congress of the International Organization for Mycoplasmology
   [Google Scholar]
10. Keeler C. L. Jr, Hnatow L. L., Whetzel P. L., Dohms J. E. ( 1996). Cloning and characterization of a putative cytadhesin gene (mgc1) from Mycoplasma gallisepticum . Infect Immun 64:1541–1547[PubMed]
    [Google Scholar]
11. Kleven S. H., Fan H. H., Turner K. S. ( 1998). Pen trial studies on the use of live vaccines to displace virulent Mycoplasma gallisepticum in chickens. Avian Dis 42:300–306 [CrossRef]
    [Google Scholar]
12. Mohammed H. O., Carpenter T. E., Yamamoto R. ( 1987). Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. Avian Dis 31:477–482 [View Article][PubMed]
    [Google Scholar]
13. Mudahi-Orenstein S., Levisohn S., Geary S. J., Yogev D. ( 2003). Cytadherence-deficient mutants of Mycoplasma gallisepticum generated by transposon mutagenesis. Infect Immun 71:3812–3820 [View Article][PubMed]
    [Google Scholar]
14. Noormohammadi A. H., Browning G. F., Cowling P. J., O’Rourke D., Whithear K. G., Markham P. F. ( 2002a). Detection of antibodies to Mycoplasma gallisepticum vaccine ts-11 by an autologous pMGA enzyme-linked immunosorbent assay. Avian Dis 46:405–411 [View Article][PubMed]
    [Google Scholar]
15. Noormohammadi A. H., Jones J. E., Underwood G., Whithear K. G. ( 2002b). Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge. Avian Dis 46:623–628 [View Article][PubMed]
    [Google Scholar]
16. Nunoya T., Tajima M., Yagihashi T., Sannai S. ( 1987). Evaluation of respiratory lesions in chickens induced by Mycoplasma gallisepticum . Nippon Juigaku Zasshi 49:621–629[PubMed] [CrossRef]
    [Google Scholar]
17. Papazisi L., Troy K. E., Gorton T. S., Liao X., Geary S. J. ( 2000). Analysis of cytadherence-deficient, GapA-negative Mycoplasma gallisepticum strain R. Infect Immun 68:6643–6649 [View Article][PubMed]
    [Google Scholar]
18. Papazisi L., Frasca S. Jr, Gladd M., Liao X., Yogev D., Geary S. J. ( 2002). GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence. Infect Immun 70:6839–6845 [View Article][PubMed]
    [Google Scholar]
19. Rodriguez R., Kleven S. H. ( 1980). Pathogenicity of two strains of Mycoplasma gallisepticum in broilers. Avian Dis 24:800–807 [View Article][PubMed]
    [Google Scholar]
20. Soeripto W., Whithear K. G., Cottew G. S., Harrigan K. E. ( 1989). Virulence and transmissibility of Mycoplasma gallisepticum . Aust Vet J 66:65–72 [View Article][PubMed]
    [Google Scholar]
21. Stipkovits L., Kempf I. ( 1996). Mycoplasmoses in poultry. Rev Sci Tech 15:1495–1525[PubMed]
    [Google Scholar]
22. Whithear K. G. 1993; Avian mycoplasmosis. Australian Standard Diagnostic Techniques for Animal Diseases1–12 Corner L. A., Bagust T. J. East Melbourne: CSIRO for the Standing Committee on Agriculture and Resource Management;
    [Google Scholar]
23. Whithear K. G. ( 1996). Control of avian mycoplasmoses by vaccination. Rev Sci Tech 15:1527–1553[PubMed]
    [Google Scholar]
24. Whithear K. G., Soeripto, Harrigan K. E., Ghiocas E. ( 1990a). Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust Vet J 67:168–174 [View Article][PubMed]
    [Google Scholar]
25. Whithear K. G., Soeripto, Harringan K. E., Ghiocas E. ( 1990b). Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust Vet J 67:159–165 [View Article][PubMed]
    [Google Scholar]
26. Yoshida S., Fujisawa A., Tsuzaki Y., Saitoh S. ( 2000). Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism. Infect Immun 68:3186–3192 [View Article][PubMed]
    [Google Scholar]